[go: up one dir, main page]

AU2002345669A1 - Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells - Google Patents

Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells

Info

Publication number
AU2002345669A1
AU2002345669A1 AU2002345669A AU2002345669A AU2002345669A1 AU 2002345669 A1 AU2002345669 A1 AU 2002345669A1 AU 2002345669 A AU2002345669 A AU 2002345669A AU 2002345669 A AU2002345669 A AU 2002345669A AU 2002345669 A1 AU2002345669 A1 AU 2002345669A1
Authority
AU
Australia
Prior art keywords
inhibit
formation
endothelial cells
antisense oligonucleotides
capillary tubes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002345669A
Other versions
AU2002345669B9 (en
AU2002345669B2 (en
Inventor
Salman Al-Mahmood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GENE SIGNAL INTERNATIONAL SA
Original Assignee
GENE SIGNAL INTERNATIONAL SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0107805A external-priority patent/FR2826010B1/en
Application filed by GENE SIGNAL INTERNATIONAL SA filed Critical GENE SIGNAL INTERNATIONAL SA
Publication of AU2002345669A1 publication Critical patent/AU2002345669A1/en
Application granted granted Critical
Publication of AU2002345669B2 publication Critical patent/AU2002345669B2/en
Assigned to GENE SIGNAL INTERNATIONAL SA reassignment GENE SIGNAL INTERNATIONAL SA Request for Assignment Assignors: GENE SIGNAL
Publication of AU2002345669B9 publication Critical patent/AU2002345669B9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002345669A 2001-06-14 2002-06-14 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells Ceased AU2002345669B9 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0107805A FR2826010B1 (en) 2001-06-14 2001-06-14 ANTISENSE OLIGONUCLEOTIDES CAPABLE OF INHIBITING THE FORMATION OF CAPILLARY TUBES BY ENDOTHELIAL CELLS
FR0107805 2001-06-14
PCT/FR2002/002067 WO2002103014A2 (en) 2001-06-14 2002-06-14 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells

Publications (3)

Publication Number Publication Date
AU2002345669A1 true AU2002345669A1 (en) 2003-05-15
AU2002345669B2 AU2002345669B2 (en) 2006-02-02
AU2002345669B9 AU2002345669B9 (en) 2006-06-29

Family

ID=8864317

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002345669A Ceased AU2002345669B9 (en) 2001-06-14 2002-06-14 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells

Country Status (13)

Country Link
US (3) US7417033B2 (en)
EP (2) EP1409672B1 (en)
JP (1) JP4153421B2 (en)
AT (1) ATE435911T1 (en)
AU (1) AU2002345669B9 (en)
CA (1) CA2451874C (en)
CY (1) CY1109464T1 (en)
DE (1) DE60232883D1 (en)
DK (1) DK1409672T3 (en)
ES (1) ES2331835T3 (en)
FR (1) FR2826010B1 (en)
PT (1) PT1409672E (en)
WO (1) WO2002103014A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007031277A2 (en) * 2005-09-14 2007-03-22 Medizinische Universität Wien Means and methods for diagnosing endometriosis
US8032556B1 (en) * 2008-03-07 2011-10-04 Symantec Corporation Systems and methods for user profile data delivery
US8470997B2 (en) 2009-02-05 2013-06-25 Gene Signal International Sa Pharmaceutical composition for preventing, stabilising and/or inhibiting blood and lymph vascularization
US8580947B2 (en) 2009-02-05 2013-11-12 Gene Signal International Sa Pharmaceutical composition for preventing, stabilising and/or inhibiting blood and lymph vascularization
US20120041047A1 (en) * 2010-08-10 2012-02-16 Gene Signal International Sa Injectable Pharmaceutical Composition for Preventing, Stabilizing and/or Inhibiting Pathological Neovascularization-Related Conditions
US9682144B2 (en) 2011-06-30 2017-06-20 Gene Signal International, Sa Composition comprising inhibitors of IRS-1 and of VEGF
EP2540828A1 (en) 2011-06-30 2013-01-02 Gene Signal International SA Composition comprising inhibitors of IRS-1 and of VEGF
WO2013001080A1 (en) 2011-06-30 2013-01-03 Gene Signal International Sa Composition comprising inhibitors of irs-1 and of vegf
US9359604B2 (en) 2012-07-03 2016-06-07 Gene Signal International Sa Inhibitor of IRS-1 for treating skin disorders
US10052343B1 (en) 2017-02-03 2018-08-21 Gene Signal International Sa Sterile formulation comprising a stable phosphorothioate oligonucleotide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0572508A4 (en) * 1991-01-18 1995-03-29 Joslin Diabetes Center Inc Nucleic acid encoding insulin receptor substrate-1 (irs-1), irs-1 protein, diseases, therapy associated with the metabolism of irs-1.
FR2733913B1 (en) * 1995-05-09 1997-08-01 Sanofi Sa DNA SEQUENCE AS A MEDICAMENT, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
US6498139B1 (en) * 1997-09-29 2002-12-24 Daiichi Pharmaceutical Co., Ltd. Remedies for diseases caused by insulin resistance
US5998148A (en) * 1999-04-08 1999-12-07 Isis Pharmaceuticals Inc. Antisense modulation of microtubule-associated protein 4 expression
EP1186667B1 (en) * 1999-05-18 2007-07-18 Dnavec Research Inc. Envelope gene-deficient virus vector of paramyxoviridae

Similar Documents

Publication Publication Date Title
GB2378707B (en) Liquid crystalline medium
AU2001269939A1 (en) Methods for eliminating the formation of biofilm
AU2002351077A1 (en) Oligonucleotides modified with novel alpha-l-rna analogues
AU2001273548A1 (en) Photoselection of nucleic acid ligands
BR0201972B1 (en) amount of suspension.
IL159309A0 (en) Nucleic acid multiplex formation
AU2002228622A1 (en) Recessed glass header for pyrotechnic initiators
AU2002312187A1 (en) Chemical micro-sensor
AU2002314997A1 (en) Methods for low background cloning of dna using long oligonucleotides
AU2002327519A1 (en) Convergent synthesis of multiporphyrin light-harvesting rods
GB2366359A8 (en) Evaporators
AU2002345669A1 (en) Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells
IL162462A0 (en) Intracellular generation of single-stranded dna
IL148155A0 (en) Large circular target-specific antisense nucleic acid compounds
PL369546A1 (en) Structural beam
AU2001281275A1 (en) Processes for the preparation of oligonucleotides
AU2001237992A1 (en) Purification of oligonucleotides
AU2003281867A1 (en) Antisense nucleic acids
WO2002103014A3 (en) Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells
AU2625801A (en) Pipet for liquid exchange
MXPA03009241A (en) Photo-activated pro-fragrances.
AU2001252390A1 (en) Nucleic acid immunization
IL162634A0 (en) Uses of an endothelial cell receptor
EP1437142A4 (en) Cell growth inhibitors
EP1421952A4 (en) Myocardial cell apoptosis inhibitors